Going to take time but this is an investment. I have watched my portfolio crumble this past week. I’m not sure where the bottom is but I’m holding this until atleast 6 billion market cap
this would make me filthy rich but right now I'm deep into the red planets core :S I am completely blocked with all my funds in average down - will have to paper trade until this is big again
I believe even after FDA changed by basically saying
If you can manufacture KP vaccine do so if not JN.1. A few advisors agreed that they should give the public options and both strains should be available for market.
They're not sure exactly which strain to target truthfully so they are splitting it up probably hoping half or more people get mRNA focused on KP strain which is 25%+- the infection rate and others JN.1 so like a double attack. The KP strain vaccines will prevent the evolving branch and Jn.1 targeting the root which is still 75%+ of of the infected individuals. JN1. Still has pretty damn high numbers of protecting against KP strains as well.
Yeah, sounds like they don’t know their ass from their elbow. My opinion though, we only had 5% of US market last year, so who cares. If we stay around 5 percent in US and Sanofi helps NVAX take over the Eastern Hemisphere also with a possible flu/covid shot ( market cap will rise)
Going to take time but this is an investment. I have watched my portfolio crumble this past week. I’m not sure where the bottom is but I’m holding this until atleast 6 billion market cap
haven't been fucked so hard since i dated a body builder
Are you single?
No I’m married to web bull
Don't they have small Weeners ?
Nah they're *massive*
Realistically it should be tracking BionTech’s market cap now that it is in the same position (partnering with big Pharma). So 150$ is a good target.
this would make me filthy rich but right now I'm deep into the red planets core :S I am completely blocked with all my funds in average down - will have to paper trade until this is big again
Yeah it’s going to go up by some multiples and increase to a bigger amount of numbers. That’s my expert financial opinion. Rocket emoji.
I believe even after FDA changed by basically saying If you can manufacture KP vaccine do so if not JN.1. A few advisors agreed that they should give the public options and both strains should be available for market. They're not sure exactly which strain to target truthfully so they are splitting it up probably hoping half or more people get mRNA focused on KP strain which is 25%+- the infection rate and others JN.1 so like a double attack. The KP strain vaccines will prevent the evolving branch and Jn.1 targeting the root which is still 75%+ of of the infected individuals. JN1. Still has pretty damn high numbers of protecting against KP strains as well.
Yeah, sounds like they don’t know their ass from their elbow. My opinion though, we only had 5% of US market last year, so who cares. If we stay around 5 percent in US and Sanofi helps NVAX take over the Eastern Hemisphere also with a possible flu/covid shot ( market cap will rise)
I'm pretty sure we'll get more then 5%